Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Carcinoma, Renal Cell × Clear all

Status

Completed 736 Terminated 224 Recruiting 218 Unknown 158 Active not recruiting 138 Withdrawn 61 Not yet recruiting 42 Suspended 9 Enrolling by invitation 5 No longer available 4 Available 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 11 Prostatic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Multiple Myeloma 6 Carcinoma, Non-Small-Cell Lung 6 Sarcoma 5 Recurrence 5 Neuroblastoma 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Stomach Neoplasms 3 Hematologic Neoplasms 3 Glioblastoma 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Primary Myelofibrosis 2 Pheochromocytoma 2 Osteosarcoma 2 Non-Muscle Invasive Bladder Neoplasms 2 Neuroectodermal Tumors, Primitive 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06090331 2025-07-08

89Zr-DFO-girentuximab Expanded Access Program (EAP)

Telix Pharmaceuticals (Innovations) Pty Limited

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡